regeneron pharmaceuticals inc nasdaqregn quotes  news  google financecookies help us deliver our services by using our services you agree to our use of cookieslearn moregot itmy accountsearchmapsyoutubeplaynewsgmaildrivecalendargoogletranslatephotosmoreshoppingwalletfinancedocsbooksbloggercontactshangoutskeepeven more from googlesign inhidden fieldssearch financeadobe flash player is required for interactive charts allowfinanceregeneron pharmaceuticals incnasdaqregnadd to portfoliocompanysummarynewsoption chainrelated companieshistorical pricesfinancialsmarketsnewsportfoliosstock screenergoogle domestic trendsrecent quotes  daysyou have no recent quoteschg   regeneron pharmaceuticals inc  public nasdaqregn   watch this stock      after hours    jul  pm edt   nasdaq realtime data  disclaimer currency in usd range     week    open  vol  avg  mkt cap b pe  divyield      eps  shares m beta  inst own  news relevance date all news for regeneron pharmaceuticals inc » subscribe advertisement events add regn to my calendars aug   q  regeneron pharmaceuticals inc earnings release  am edt  aug   q  regeneron pharmaceuticals inc earnings call  am edt  jun   regeneron pharmaceuticals inc at goldman sachs global healthcare conference  jun   regeneron pharmaceuticals inc annual shareholders meeting  may   regeneron pharmaceuticals inc at sanford c bernstein strategic decision conference  may   regeneron pharmaceuticals inc at bank of america merrill lynch healthcare conference  may   q  regeneron pharmaceuticals inc earnings release may   q  regeneron pharmaceuticals inc earnings call  more events from dailyfinance »     key stats and ratios q mar   net profit margin   operating margin   ebitd margin   return on average assets   return on average equity   employees   cdp score  b screen stocks with similar metrics » address  old saw mill river rdtarrytown ny united states  map phone website links httpwwwregeneroncom external links analyst estimates  marketwatch sec filings  edgar online major holders  msn money research reports  reuters settings  technicals  link to this view volume delayed by  minsprices are not from all markets sources include six advertisement related companies show most recent quarter most recent annual add or remove columns save changes cancel sector healthcare  industry bio therapeutic drugs more from factset » description regeneron pharmaceuticals inc is a biopharmaceutical company that discovers invents develops manufactures and commercializes medicines for the treatment of serious medical conditions the company commercializes medicines for eye diseases high lowdensity lipoprotein ldl cholesterol and an inflammatory condition and have product candidates in development in other areas including rheumatoid arthritis asthma atopic dermatitis pain cancer and infectious diseases the companys marketed products include eylea aflibercept injection praluent alirocumab injection arcalyst rilonacept injection for subcutaneous use kevzara sarilumab solution for subcutaneous injection and zaltrap zivaflibercept injection for intravenous infusion as of december   the company had  product candidates in clinical development which consisted of a trapbased clinical program and  fully human monoclonal antibody product candidates more from reuters » officers and directors p roy vagelos md chairman of the board age  bio  compensation   reuters leonard s schleifer md phd president chief executive officer director age  bio  compensation   reuters robert e landry chief financial officer senior vice president  finance age  bio  compensation   reuters daniel p van plew executive vice president general manager  industrial operations and product supply age  bio  compensation   reuters neil stahl phd executive vice president  research and development age  bio  compensation   reuters robert j terifay executive vice president  commercial age  bio  compensation   reuters joseph j larosa senior vice president general counsel secretary age  bio  compensation   reuters michael aberman md senior vice president  strategy and investor relation age  bio  compensation   reuters peter powchik md senior vice president  clinical development age  bio  compensation   reuters george d yancopoulos md phd president and chief scientific officer  regeneron director age  bio  compensation   reuters full list on reuters » google finance beta available in hong kong  canada  us  china  ukinformation is provided as is and solely for informational purposes not for trading purposes or advice and may be delayedto see all exchange delays please see disclaimer google  google home  blog  help  report a problem  privacy policy  terms of service regeneron  wikipedia regeneron from wikipedia the free encyclopedia jump to navigation search regeneron pharmaceuticals inc type public traded as nasdaq regn nasdaq component sp  component industry pharmaceuticals biotech founded  headquarters tarrytown new york us headquarters area served worldwide key people leonard schleifer ceo george yancopoulos cso revenue  billion net income  billion total assets  billion owner sanofi  website wwwregeneroncom regeneron pharmaceuticals inc is a biotechnology company headquartered in tarrytown new york the company was founded in  originally focused on neurotrophic factors and their regenerative capabilities thus the name it branched out into the study of both cytokine and tyrosine kinase receptors contents  company history  marketed products  technology platforms  financial performance  see also  references  external links company historyedit regeneron has two products in development based on aflibercept a vegf inhibitor and rilonacept an interleukin blocker vegf is a protein that normally stimulates the growth of blood vessels and interleukin is a protein that is normally involved in inflammation on march   bloomberg announced that sanofi and regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to  more than the leading brands it is believed this new drug will greatly reduce heart disease in patients around the world the medicine one in a class of drugs targeting the pcsk gene reduced patients’ average ldl cholesterol levels to as little as  milligrams per deciliter after  weeks in the mid stage study presented on march  at the american college of cardiology meeting in chicagocitation needed in july  the company announced a new global collaboration with sanofi to discover develop and commercialise new immunooncology drugs which could generate more than  billion for regeneron with  million upfront  million for proof of concept data and  million from the development of regn marketed productsedit eylea aflibercept injection approved by the us food and drug administration fda in november  eylea developed to treat a common cause of blindness in the elderly arcalyst rilonacept for specific rare autoinflammatory conditions approved by the fda in february  zaltrap aflibercept injection for metastatic colorectal cancer approved by the fda in august  praluent alirocumab indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease ascvd who require additional lowering of lowdensity lipoprotein ldl cholesterol approved by fda on  july   technology platformsedit trap fusion proteins regeneron’s novel and patented trap technology creates highaffinity product candidates for many types of signaling molecules including growth factors and cytokines the trap technology involves fusing two distinct fully human receptor components and a fully human immunoglobuling constant region fully human monoclonal antibodies regeneron has developed a suite velocisuite of patented technologies including velocimmune and velocimab that allow regeneron scientists to determine the best targets for therapeutic intervention and rapidly generate highquality fully human antibodies drug candidates addressing these targets financial performanceedit financial year revenue ref   billion    billion    billion    billion  see alsoedit biotech and pharmaceutical companies in the new york metropolitan area referencesedit  a b c d e httpfilesshareholdercomdownloadsregnxxccdacederegnnewsgeneralreleasespdf  shareholders managers and business summary  traders retrieved april     a b herper matthew august   how two guys from queens are changing drug discovery forbes united states archived from the original on march   retrieved march     regeneron sanofi launch b immunooncology collaboration  gen news highlights  gen   updated struggling sanofi paying b to partner with regeneron on immunooncology  fiercebiotech   regulators approve a drug for an eye condition the new york times associated press november   registration required  fda approves zaltrap for metastatic colorectal cancer press release us food and drug administration august   archived from the original on june     httpwwwfdagovnewseventsnewsroompressannouncementsucmhtm  susana magadán mompó and áfrica gonzálezfernández human monoclonal antibodies from transgenic mice chapter  in human monoclonal antibodies methods and protocols ed michael steinitz springer sciencebusiness media  isbn   regeneron pharmaceuticals inc  annual report form k xbrl united states securities and exchange commission february     regeneron pharmaceuticals inc  annual report form k xbrl united states securities and exchange commission february    external linksedit official website business data for regeneron google finance yahoo finance reuters sec filings success long in coming for eylea a vision treatment v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies v t e companies of the nasdaq index st century fox activision blizzard adobe systems akamai technologies alexion pharmaceuticals alphabet amazoncom american airlines group amgen analog devices apple applied materials autodesk automatic data processing baidu biogen biomarin pharmaceutical broadcom limited ca technologies celgene cerner charter communications check point cintas cisco systems citrix systems cognizant comcast costco csx ctripcom international dentsply sirona discovery communications dish network dollar tree ebay electronic arts expedia express scripts facebook fastenal fiserv gilead sciences hasbro henry schein hologic idexx laboratories illumina incyte intel intuit intuitive surgical j b hunt transport services jdcom klatencor kraft heinz lam research liberty global liberty interactive marriott international mattel maxim integrated products mercadolibre microchip technology micron technology microsoft mondelez international monster beverage mylan netease netflix norwegian cruise line nvidia oreilly auto parts paccar paychex paypal qualcomm regeneron ross stores seagate technology shire sirius xm holdings skyworks solutions starbucks symantec tmobile us tesla inc texas instruments the priceline group tractor supply company ulta beauty verisk analytics vertex pharmaceuticals viacom vodafone walgreens boots alliance western digital wynn resorts xilinx retrieved from httpsenwikipediaorgwindexphptitleregeneronoldid categories companies in the nasdaq indexcompanies listed on nasdaqhealth care companies based in new yorkbiotechnology companies of the united statescompanies in the nasdaq biotechnology indexpharmaceutical companies of the united stateslife sciences industryhidden categories pages with login required references or sourcespages using deprecated image syntaxall articles with unsourced statementsarticles with unsourced statements from may  navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages deutschfrançaisукраїнська edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view regeneron  wikipedia regeneron from wikipedia the free encyclopedia jump to navigation search regeneron pharmaceuticals inc type public traded as nasdaq regn nasdaq component sp  component industry pharmaceuticals biotech founded  headquarters tarrytown new york us headquarters area served worldwide key people leonard schleifer ceo george yancopoulos cso revenue  billion net income  billion total assets  billion owner sanofi  website wwwregeneroncom regeneron pharmaceuticals inc is a biotechnology company headquartered in tarrytown new york the company was founded in  originally focused on neurotrophic factors and their regenerative capabilities thus the name it branched out into the study of both cytokine and tyrosine kinase receptors contents  company history  marketed products  technology platforms  financial performance  see also  references  external links company historyedit regeneron has two products in development based on aflibercept a vegf inhibitor and rilonacept an interleukin blocker vegf is a protein that normally stimulates the growth of blood vessels and interleukin is a protein that is normally involved in inflammation on march   bloomberg announced that sanofi and regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to  more than the leading brands it is believed this new drug will greatly reduce heart disease in patients around the world the medicine one in a class of drugs targeting the pcsk gene reduced patients’ average ldl cholesterol levels to as little as  milligrams per deciliter after  weeks in the mid stage study presented on march  at the american college of cardiology meeting in chicagocitation needed in july  the company announced a new global collaboration with sanofi to discover develop and commercialise new immunooncology drugs which could generate more than  billion for regeneron with  million upfront  million for proof of concept data and  million from the development of regn marketed productsedit eylea aflibercept injection approved by the us food and drug administration fda in november  eylea developed to treat a common cause of blindness in the elderly arcalyst rilonacept for specific rare autoinflammatory conditions approved by the fda in february  zaltrap aflibercept injection for metastatic colorectal cancer approved by the fda in august  praluent alirocumab indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease ascvd who require additional lowering of lowdensity lipoprotein ldl cholesterol approved by fda on  july   technology platformsedit trap fusion proteins regeneron’s novel and patented trap technology creates highaffinity product candidates for many types of signaling molecules including growth factors and cytokines the trap technology involves fusing two distinct fully human receptor components and a fully human immunoglobuling constant region fully human monoclonal antibodies regeneron has developed a suite velocisuite of patented technologies including velocimmune and velocimab that allow regeneron scientists to determine the best targets for therapeutic intervention and rapidly generate highquality fully human antibodies drug candidates addressing these targets financial performanceedit financial year revenue ref   billion    billion    billion    billion  see alsoedit biotech and pharmaceutical companies in the new york metropolitan area referencesedit  a b c d e httpfilesshareholdercomdownloadsregnxxccdacederegnnewsgeneralreleasespdf  shareholders managers and business summary  traders retrieved april     a b herper matthew august   how two guys from queens are changing drug discovery forbes united states archived from the original on march   retrieved march     regeneron sanofi launch b immunooncology collaboration  gen news highlights  gen   updated struggling sanofi paying b to partner with regeneron on immunooncology  fiercebiotech   regulators approve a drug for an eye condition the new york times associated press november   registration required  fda approves zaltrap for metastatic colorectal cancer press release us food and drug administration august   archived from the original on june     httpwwwfdagovnewseventsnewsroompressannouncementsucmhtm  susana magadán mompó and áfrica gonzálezfernández human monoclonal antibodies from transgenic mice chapter  in human monoclonal antibodies methods and protocols ed michael steinitz springer sciencebusiness media  isbn   regeneron pharmaceuticals inc  annual report form k xbrl united states securities and exchange commission february     regeneron pharmaceuticals inc  annual report form k xbrl united states securities and exchange commission february    external linksedit official website business data for regeneron google finance yahoo finance reuters sec filings success long in coming for eylea a vision treatment v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies v t e companies of the nasdaq index st century fox activision blizzard adobe systems akamai technologies alexion pharmaceuticals alphabet amazoncom american airlines group amgen analog devices apple applied materials autodesk automatic data processing baidu biogen biomarin pharmaceutical broadcom limited ca technologies celgene cerner charter communications check point cintas cisco systems citrix systems cognizant comcast costco csx ctripcom international dentsply sirona discovery communications dish network dollar tree ebay electronic arts expedia express scripts facebook fastenal fiserv gilead sciences hasbro henry schein hologic idexx laboratories illumina incyte intel intuit intuitive surgical j b hunt transport services jdcom klatencor kraft heinz lam research liberty global liberty interactive marriott international mattel maxim integrated products mercadolibre microchip technology micron technology microsoft mondelez international monster beverage mylan netease netflix norwegian cruise line nvidia oreilly auto parts paccar paychex paypal qualcomm regeneron ross stores seagate technology shire sirius xm holdings skyworks solutions starbucks symantec tmobile us tesla inc texas instruments the priceline group tractor supply company ulta beauty verisk analytics vertex pharmaceuticals viacom vodafone walgreens boots alliance western digital wynn resorts xilinx retrieved from httpsenwikipediaorgwindexphptitleregeneronoldid categories companies in the nasdaq indexcompanies listed on nasdaqhealth care companies based in new yorkbiotechnology companies of the united statescompanies in the nasdaq biotechnology indexpharmaceutical companies of the united stateslife sciences industryhidden categories pages with login required references or sourcespages using deprecated image syntaxall articles with unsourced statementsarticles with unsourced statements from may  navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages deutschfrançaisукраїнська edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view regeneron  wikipedia regeneron from wikipedia the free encyclopedia jump to navigation search regeneron pharmaceuticals inc type public traded as nasdaq regn nasdaq component sp  component industry pharmaceuticals biotech founded  headquarters tarrytown new york us headquarters area served worldwide key people leonard schleifer ceo george yancopoulos cso revenue  billion net income  billion total assets  billion owner sanofi  website wwwregeneroncom regeneron pharmaceuticals inc is a biotechnology company headquartered in tarrytown new york the company was founded in  originally focused on neurotrophic factors and their regenerative capabilities thus the name it branched out into the study of both cytokine and tyrosine kinase receptors contents  company history  marketed products  technology platforms  financial performance  see also  references  external links company historyedit regeneron has two products in development based on aflibercept a vegf inhibitor and rilonacept an interleukin blocker vegf is a protein that normally stimulates the growth of blood vessels and interleukin is a protein that is normally involved in inflammation on march   bloomberg announced that sanofi and regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to  more than the leading brands it is believed this new drug will greatly reduce heart disease in patients around the world the medicine one in a class of drugs targeting the pcsk gene reduced patients’ average ldl cholesterol levels to as little as  milligrams per deciliter after  weeks in the mid stage study presented on march  at the american college of cardiology meeting in chicagocitation needed in july  the company announced a new global collaboration with sanofi to discover develop and commercialise new immunooncology drugs which could generate more than  billion for regeneron with  million upfront  million for proof of concept data and  million from the development of regn marketed productsedit eylea aflibercept injection approved by the us food and drug administration fda in november  eylea developed to treat a common cause of blindness in the elderly arcalyst rilonacept for specific rare autoinflammatory conditions approved by the fda in february  zaltrap aflibercept injection for metastatic colorectal cancer approved by the fda in august  praluent alirocumab indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease ascvd who require additional lowering of lowdensity lipoprotein ldl cholesterol approved by fda on  july   technology platformsedit trap fusion proteins regeneron’s novel and patented trap technology creates highaffinity product candidates for many types of signaling molecules including growth factors and cytokines the trap technology involves fusing two distinct fully human receptor components and a fully human immunoglobuling constant region fully human monoclonal antibodies regeneron has developed a suite velocisuite of patented technologies including velocimmune and velocimab that allow regeneron scientists to determine the best targets for therapeutic intervention and rapidly generate highquality fully human antibodies drug candidates addressing these targets financial performanceedit financial year revenue ref   billion    billion    billion    billion  see alsoedit biotech and pharmaceutical companies in the new york metropolitan area referencesedit  a b c d e httpfilesshareholdercomdownloadsregnxxccdacederegnnewsgeneralreleasespdf  shareholders managers and business summary  traders retrieved april     a b herper matthew august   how two guys from queens are changing drug discovery forbes united states archived from the original on march   retrieved march     regeneron sanofi launch b immunooncology collaboration  gen news highlights  gen   updated struggling sanofi paying b to partner with regeneron on immunooncology  fiercebiotech   regulators approve a drug for an eye condition the new york times associated press november   registration required  fda approves zaltrap for metastatic colorectal cancer press release us food and drug administration august   archived from the original on june     httpwwwfdagovnewseventsnewsroompressannouncementsucmhtm  susana magadán mompó and áfrica gonzálezfernández human monoclonal antibodies from transgenic mice chapter  in human monoclonal antibodies methods and protocols ed michael steinitz springer sciencebusiness media  isbn   regeneron pharmaceuticals inc  annual report form k xbrl united states securities and exchange commission february     regeneron pharmaceuticals inc  annual report form k xbrl united states securities and exchange commission february    external linksedit official website business data for regeneron google finance yahoo finance reuters sec filings success long in coming for eylea a vision treatment v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies v t e companies of the nasdaq index st century fox activision blizzard adobe systems akamai technologies alexion pharmaceuticals alphabet amazoncom american airlines group amgen analog devices apple applied materials autodesk automatic data processing baidu biogen biomarin pharmaceutical broadcom limited ca technologies celgene cerner charter communications check point cintas cisco systems citrix systems cognizant comcast costco csx ctripcom international dentsply sirona discovery communications dish network dollar tree ebay electronic arts expedia express scripts facebook fastenal fiserv gilead sciences hasbro henry schein hologic idexx laboratories illumina incyte intel intuit intuitive surgical j b hunt transport services jdcom klatencor kraft heinz lam research liberty global liberty interactive marriott international mattel maxim integrated products mercadolibre microchip technology micron technology microsoft mondelez international monster beverage mylan netease netflix norwegian cruise line nvidia oreilly auto parts paccar paychex paypal qualcomm regeneron ross stores seagate technology shire sirius xm holdings skyworks solutions starbucks symantec tmobile us tesla inc texas instruments the priceline group tractor supply company ulta beauty verisk analytics vertex pharmaceuticals viacom vodafone walgreens boots alliance western digital wynn resorts xilinx retrieved from httpsenwikipediaorgwindexphptitleregeneronoldid categories companies in the nasdaq indexcompanies listed on nasdaqhealth care companies based in new yorkbiotechnology companies of the united statescompanies in the nasdaq biotechnology indexpharmaceutical companies of the united stateslife sciences industryhidden categories pages with login required references or sourcespages using deprecated image syntaxall articles with unsourced statementsarticles with unsourced statements from may  navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages deutschfrançaisукраїнська edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view flashratings  about us facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings  all research for my stocks the most comprehensive equity research coverage available online never miss a single piece of research upgrade downgrade or target price change by any analyst firm on any stock equity research by professional analysts  especially their rationales more than their forecasts  contains far more interesting and important information about the actual fundamentals of the traded companies than can be gathered from conventional news reports our mission is to unlock access to valuable research on stocks for all retail investors professionals institutions take advantage of our costeffective subscriptions to have flashratingss comprehensive realtime feed delivered into your intranet and trading floor platforms institutional subscriptions websites become a content licensing partner and display flashratingss popular news feed on your website content licensing advertisers advertise with us and have flashratings readers with attractive demographics take advantage of your products advertising regnnasdaq gs stock quote  regeneron pharmaceuticals inc  bloomberg markets error could not add to watchlist x  watchlist regeneron pharmaceuticals inc regnus nasdaq gs usd   as of  pm edt  open  day range    volume  previous close  wk range     yr return  before its here its on the bloomberg terminal learn more open  day range    volume  previous close  wk range     yr return  ytd return  current pe ratio ttm  earnings per share usd ttm  market cap b usd  shares outstanding m  pricesales ttm  dividend indicated gross yield  sector health care  price change  industry pharmaceuticals biotechnology  life sciences  price change  related videos there are currently no related videos for this ticker please check back later company news press releases  will pandora shares soar to   or plummet to   the street  healthcare stock rally cant save sp  from another bad day  the street  healthcare rally cant save sp  from another down day  the street  nasdaq leads wall street healthcare stocks rise on senate bill  the street  nasdaq leads wall street healthcare stocks rise on senate bill  the street  regeneron rises after novartiss eyedrug trials disappoint there are currently no news stories for this ticker please check back later an hour ago merus nv us court of appeals for the federal circuit affirms merus inequitable conduct claim against regeneron an hour ago us court of appeals for the federal circuit affirms merus’ inequitable conduct claim against regeneron  ophthalmic drugs market to reach us billion by  players entering into codevelopment agreements to enhance product  dermatological drugs market forecast   diabetic macular edema pipeline therapeutics companies and drugs profile insights  available at rnr market research  sanofi receives chmp positive opinion for dupixent® dupilumab to treat adult patients with moderatetosevere atopic  sanofi and regeneron receive positive chmp opinion for dupixent® dupilumab to treat adult patients with moderatetosevere  sanofi sanofi and regeneron receive positive chmp opinion for dupixent® dupilumab to treat adult patients with moderateto  regeneron and sanofi receive positive chmp opinion for dupixent® dupilumab to treat adult patients with moderatetosevere a  asthma therapeutics in asiapacific market to   high prevalence highly priced existing and upcoming biologics will drive there are currently no press releases for this ticker please check back later profile regeneron pharmaceuticals inc is a biopharmaceutical company the company discovers develops and commercializes pharmaceutical products for the treatment of serious medical conditions regeneron pharmaceuticals serves the healthcare sector in the united states address  old saw mill river roadtarrytown ny united states phone  website wwwregeneroncom executives board members leonard s schleifer copresidentceocofounder george d yancopoulos copresidentchief scientific ofcr daniel p van plew exec vpgen mgrindustrial ops neil stahl exec vpresearch  development robert e landry bob senior vpfinancecfo show more regeneron pharmaceuticals inc  product pipeline review    compare about us  contact us home research category publisher list custom research cart compare research category user guide policies contact us about us site map home  market research report  pharmaceutical  pharmaceutical companies  pharma info market research report regeneron pharmaceuticals inc  product pipeline review   published by global markets direct product code  published april   content info  pages price usd  pdf by email single user license usd  pdf by email site license usd  pdf by email global license regeneron pharmaceuticals inc  product pipeline review   published april   content info  pages description summary global markets directs regeneron pharmaceuticals inc  product pipeline review   provides an overview of the regeneron pharmaceuticals incs pharmaceutical research and development focus the report provides comprehensive information on the therapeutics under development by regeneron pharmaceuticals inc complete with analysis by stage of development drug target mechanism of action moa route of administration roa and molecule type the report also covers the descriptive pharmacological action of the therapeutics its complete research and development history and the dormant and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites clinical trial registries conferences sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis the report helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage note certain sections in the report may be removed or altered based on the availability and relevance of data scope the report provides a snapshot of the pipeline therapeutic landscape of regeneron pharmaceuticals inc the report provides overview of regeneron pharmaceuticals inc including its business description key facts and locations and subsidiaries the report features descriptive drug profiles for the pipeline products which includes product description descriptive moa rd brief licensing and collaboration details  other developmental activities the report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages the report assesses regeneron pharmaceuticals incs pipeline therapeutics based on drug target mechanism of action moa route of administration roa and molecule type the report features regeneron pharmaceuticals incs outlicensed and partnered product portfolio and summarizes its dormant and discontinued projects reasons to buy evaluate regeneron pharmaceuticals incs strategic position with total access to detailed information on its product pipeline gain strategically significant competitor information analysis and insights to formulate effective rd strategies identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage identify and understand important and diverse types of therapeutics under development for regeneron pharmaceuticals inc identify potential new clients or partners in the target demographic plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics devise corrective measures for pipeline projects by understanding regeneron pharmaceuticals incs pipeline depth and focus of pipeline therapeutics develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope table of contents product code gmdhccdbtable of contents table of contents list of tables list of figures introduction global markets direct report coverage regeneron pharmaceuticals inc snapshot regeneron pharmaceuticals inc overview key information key facts regeneron pharmaceuticals inc  research and development overview key therapeutic areas regeneron pharmaceuticals inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  combination treatment modalities pipeline products  partnered products partnered productscombination treatment modalities regeneron pharmaceuticals inc  pipeline products glance regeneron pharmaceuticals inc  late stage pipeline products preregistration productscombination treatment modalities phase iii productscombination treatment modalities regeneron pharmaceuticals inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities regeneron pharmaceuticals inc  early stage pipeline products preclinical productscombination treatment modalities discovery productscombination treatment modalities regeneron pharmaceuticals inc  drug profiles aflibercept product description mechanism of action rd progress alirocumab product description mechanism of action rd progress sarilumab product description mechanism of action rd progress dupilumab product description mechanism of action rd progress suptavumab product description mechanism of action rd progress fasinumab product description mechanism of action rd progress aflibercept  nesvacumab product description mechanism of action rd progress aflibercept  rinucumab product description mechanism of action rd progress evinacumab product description mechanism of action rd progress trevogrumab product description mechanism of action rd progress zivaflibercept recombinant product description mechanism of action rd progress regn product description mechanism of action rd progress regn product description mechanism of action rd progress regn product description mechanism of action rd progress monoclonal antibodies for ebola virus infection product description mechanism of action rd progress monoclonal antibodies for middle east respiratory syndrome product description mechanism of action rd progress monoclonal antibody to agonize gitr for oncology product description mechanism of action rd progress monoclonal antibody to inhibit lag for oncology product description mechanism of action rd progress monoclonal antibody to inhibit pdl for oncology product description mechanism of action rd progress oligonucleotides to inhibit transthyretin for amyloidosis product description mechanism of action rd progress regn product description mechanism of action rd progress monoclonal antibodies for blood cancer and solid tumor product description mechanism of action rd progress regeneron pharmaceuticals inc  pipeline analysis regeneron pharmaceuticals inc  pipeline products by target regeneron pharmaceuticals inc  pipeline products by route of administration regeneron pharmaceuticals inc  pipeline products by molecule type regeneron pharmaceuticals inc  pipeline products by mechanism of action regeneron pharmaceuticals inc  recent pipeline updates regeneron pharmaceuticals inc  dormant projects regeneron pharmaceuticals inc  discontinued pipeline products discontinued pipeline product profiles crotedumab dapiclermin enoticumab nesvacumab regn regn rilonacept zivaflibercept recombinant regeneron pharmaceuticals inc  company statement regeneron pharmaceuticals inc  locations and subsidiaries head office other locations  subsidiaries regeneron pharmaceuticals inc  key manufacturing facilities appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tables regeneron pharmaceuticals inc key information regeneron pharmaceuticals inc key facts regeneron pharmaceuticals inc  pipeline by indication  regeneron pharmaceuticals inc  pipeline by stage of development  regeneron pharmaceuticals inc  monotherapy products in pipeline  regeneron pharmaceuticals inc  combination treatment modalities in pipeline  regeneron pharmaceuticals inc  partnered products in pipeline  regeneron pharmaceuticals inc  partnered products combination treatment modalities  regeneron pharmaceuticals inc  preregistration  regeneron pharmaceuticals inc  phase iii  regeneron pharmaceuticals inc  phase ii  regeneron pharmaceuticals inc  phase i  regeneron pharmaceuticals inc  preclinical  regeneron pharmaceuticals inc  discovery  regeneron pharmaceuticals inc  pipeline by target  regeneron pharmaceuticals inc  pipeline by route of administration  regeneron pharmaceuticals inc  pipeline by molecule type  regeneron pharmaceuticals inc  pipeline products by mechanism of action  regeneron pharmaceuticals inc  recent pipeline updates  regeneron pharmaceuticals inc  dormant developmental projects regeneron pharmaceuticals inc  discontinued pipeline products  regeneron pharmaceuticals inc other locations regeneron pharmaceuticals inc subsidiaries regeneron pharmaceuticals inc key manufacturing facilities list of figures regeneron pharmaceuticals inc  pipeline by top  indication  regeneron pharmaceuticals inc  pipeline by stage of development  regeneron pharmaceuticals inc  monotherapy products in pipeline  regeneron pharmaceuticals inc  partnered products in pipeline  regeneron pharmaceuticals inc  pipeline by top  target  regeneron pharmaceuticals inc  pipeline by top  route of administration  regeneron pharmaceuticals inc  pipeline by top  molecule type  regeneron pharmaceuticals inc  pipeline products by top  mechanism of action  phone intl  tollfreeus  europe  asia  new for   gii now purchases any market research reports from any publishers for you with noextra cost contact us for more details faq delivery time user license payment options compare multiple reports related reports head and neck cancer  pipeline review h  published may   alchemia ltd  product pipeline review   published dec   array biopharma inc  product pipeline review   published dec   bionomics ltd  product pipeline review   published dec   chong kun dang pharmaceutical corp  product pipeline review   published dec   csl ltd  product pipeline review   published dec   genervon biopharmaceuticals llc  product pipeline review   published dec   genethon sa  product pipeline review   published dec   hutchison medipharma ltd  product pipeline review   published dec   hyundai pharmaceutical co ltd  product pipeline review   published dec   ▼ about contact user guide policies site map  copyright  global information inc all rights reserved data dumps    freebase api deprecated    google developers freebase api deprecated all products sign in send feedback hey there are you maybe looking for firebase instead data dumps the freebase api will be completely shutdown on aug   this page provides access to the last available data dump read more data dumps are a downloadable version of the data in freebase they constitute a snapshot of the data stored in freebase and the schema that structures it and are provided under the same ccby license the freebasewikidata mappings are provided under the cc license freebase triples freebase deleted triples freebasewikidata mappings license citing freebase triples this dataset contains every fact currently in freebase total triples  billion updated weekly data format ntriples rdf license ccby  gb gzip gb uncompressed download the rdf data is serialized using the ntriples format encoded as utf text and compressed with gzip rdf httprdffreebasecomnsgvjzynm httprdffreebasecomnsmeasurementunitdatedpercentagedate httpwwwworgxmlschemagyearmonth  httprdffreebasecomnsgvjzynm httprdffreebasecomnsmeasurementunitdatedpercentagesource httprdffreebasecomnsgxgfm  httprdffreebasecomnsgvjzynm httprdffreebasecomnstypeobjecttype httprdffreebasecomnsmeasurementunitdatedpercentage  httprdffreebasecomnsgvjzynm httprdffreebasecomnsmeasurementunitdatedpercentagerate   httprdffreebasecomnsgvjzynm httpwwwworgrdfsyntaxnstype httprdffreebasecomnsmeasurementunitdatedpercentage  if youre writing your own code to parse the rdf dumps its often more efficient to read directly from gzip file rather than extracting the data first and then processing the uncompressed data subject predicate object  note in freebase objects have mids that look like mrkqx in rdf those mids become mrkqx likewise freebase schema like commontopic are written as commontopic the subject is the id of a freebase object it can be a freebase mid ex mrkqx for topics and cvts or a humanreadable id ex commontopic for schema the predicate is always a humanreadable id for a freebase property or a property from a standard rdf vocabulary like rdfs freebase foreign key namespaces are also used as predicates to make it easier to look up keys by namespace the object field may contain a freebase mid for an object or a humanreadable id for schema from freebase or other rdf vocabularies it may also include literal values like strings booleans and numeric values topic descriptions often contain newlines in order to make each triple fit on one line we have escaped newlines with n freebase deleted triples we also provide a dump of triples that have been deleted from freebase over time this is a onetime dump through march  in the future we might consider providing periodic updates of recently deleted triples but at the moment we have no specific timeframe for doing so and are only providing this onetime dump the dump is distributed as a targz file gb compressed gb uncompressed it contains  deleted triples in  files there is no particular meaning to the individual files it is just easier to manipulate several smaller files than one huge file thanks to chun how tan and john giannandrea for making this data release possible total triples  million updated june   data format csv license ccby  gb gzip gb uncompressed download the data format is essentially csv with one important caveat the object field may contain any characters including commas as well as any other reasonable delimiters you could think of however all the other fields are guaranteed not to contain commas so the data can still be parsed unambiguously the columns in the dataset are defined as creationtimestamp unix epoch time in milliseconds creator deletiontimestamp unix epoch time in milliseconds deletor subject mid predicate mid object midliteral languagecode csv usermwclwikipediaenusermwclwikipediaenmrtypeobjectkeywikipediaenben usermwclmusicbrainzuserturtlewaxbotmnncpzmusicrecordingartistmvbfmen usermwclimagesusergardeningbotmwmcommonimagesizemklyen usermwclmusicbrainzusermbzpipelinemergebotmfvvltypeobjecttypecommontopicen usermwclimagesusergardeningbotmxsczcommonlicensedobjectlicensemxben usercontentadministratorusergardeningbotmgkbytypeobjecttypetypecontenten usermwclimagesusergardeningbotmhcommontopicimagemcsen usermwclchefmozuserdeletebotmzcztypeobjectnamela casa rosa mexican restauranten freebasewikidata mappings the data has been created based on the wikidatadump of october   and contains only those links that have at least two common wikipedialinks and not a single disagreeing wikipedialink furthermore the lines are sorted by the number of common wikipedialinks although in turtle this does not really matter total triples m updated october   data format ntriples rdf license cc  mb gzip mb uncompressed download the rdf data is serialized using the ntriples format encoded as utf text and compressed with gzip rdf httprdffreebasecomnsmj httpwwwworgowlsameas httpwwwwikidataorgentityq  httprdffreebasecomnsmnrg httpwwwworgowlsameas httpwwwwikidataorgentityq  httprdffreebasecomnsmjgd httpwwwworgowlsameas httpwwwwikidataorgentityq  httprdffreebasecomnsmd httpwwwworgowlsameas httpwwwwikidataorgentityq  httprdffreebasecomnsmgd httpwwwworgowlsameas httpwwwwikidataorgentityq  license freebase data dumps are provided free of charge for any purpose with regular updates by google they are distributed like freebase itself under the creative commons attribution aka ccby and use is subject to the terms of service the freebasewikidata id mappings are provided under cc and can be used without restrictions citing if youd like to cite these data dumps in a publication you may use google freebase data dumps httpsdevelopersgooglecomfreebasedata month day year or as bibtex bibtex misc except as otherwise noted the content of this page is licensed under the creative commons attribution  license and code samples are licensed under the apache  license for details see our site policies java is a registered trademark of oracle andor its affiliates last updated february   send feedback about this page documentation feedback freebase api deprecated product feedback cancel regeneron  wikipedia regeneron from wikipedia the free encyclopedia jump to navigation search regeneron pharmaceuticals inc type public traded as nasdaq regn nasdaq component sp  component industry pharmaceuticals biotech founded  headquarters tarrytown new york us headquarters area served worldwide key people leonard schleifer ceo george yancopoulos cso revenue  billion net income  billion total assets  billion owner sanofi  website wwwregeneroncom regeneron pharmaceuticals inc is a biotechnology company headquartered in tarrytown new york the company was founded in  originally focused on neurotrophic factors and their regenerative capabilities thus the name it branched out into the study of both cytokine and tyrosine kinase receptors contents  company history  marketed products  technology platforms  financial performance  see also  references  external links company historyedit regeneron has two products in development based on aflibercept a vegf inhibitor and rilonacept an interleukin blocker vegf is a protein that normally stimulates the growth of blood vessels and interleukin is a protein that is normally involved in inflammation on march   bloomberg announced that sanofi and regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to  more than the leading brands it is believed this new drug will greatly reduce heart disease in patients around the world the medicine one in a class of drugs targeting the pcsk gene reduced patients’ average ldl cholesterol levels to as little as  milligrams per deciliter after  weeks in the mid stage study presented on march  at the american college of cardiology meeting in chicagocitation needed in july  the company announced a new global collaboration with sanofi to discover develop and commercialise new immunooncology drugs which could generate more than  billion for regeneron with  million upfront  million for proof of concept data and  million from the development of regn marketed productsedit eylea aflibercept injection approved by the us food and drug administration fda in november  eylea developed to treat a common cause of blindness in the elderly arcalyst rilonacept for specific rare autoinflammatory conditions approved by the fda in february  zaltrap aflibercept injection for metastatic colorectal cancer approved by the fda in august  praluent alirocumab indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease ascvd who require additional lowering of lowdensity lipoprotein ldl cholesterol approved by fda on  july   technology platformsedit trap fusion proteins regeneron’s novel and patented trap technology creates highaffinity product candidates for many types of signaling molecules including growth factors and cytokines the trap technology involves fusing two distinct fully human receptor components and a fully human immunoglobuling constant region fully human monoclonal antibodies regeneron has developed a suite velocisuite of patented technologies including velocimmune and velocimab that allow regeneron scientists to determine the best targets for therapeutic intervention and rapidly generate highquality fully human antibodies drug candidates addressing these targets financial performanceedit financial year revenue ref   billion    billion    billion    billion  see alsoedit biotech and pharmaceutical companies in the new york metropolitan area referencesedit  a b c d e httpfilesshareholdercomdownloadsregnxxccdacederegnnewsgeneralreleasespdf  shareholders managers and business summary  traders retrieved april     a b herper matthew august   how two guys from queens are changing drug discovery forbes united states archived from the original on march   retrieved march     regeneron sanofi launch b immunooncology collaboration  gen news highlights  gen   updated struggling sanofi paying b to partner with regeneron on immunooncology  fiercebiotech   regulators approve a drug for an eye condition the new york times associated press november   registration required  fda approves zaltrap for metastatic colorectal cancer press release us food and drug administration august   archived from the original on june     httpwwwfdagovnewseventsnewsroompressannouncementsucmhtm  susana magadán mompó and áfrica gonzálezfernández human monoclonal antibodies from transgenic mice chapter  in human monoclonal antibodies methods and protocols ed michael steinitz springer sciencebusiness media  isbn   regeneron pharmaceuticals inc  annual report form k xbrl united states securities and exchange commission february     regeneron pharmaceuticals inc  annual report form k xbrl united states securities and exchange commission february    external linksedit official website business data for regeneron google finance yahoo finance reuters sec filings success long in coming for eylea a vision treatment v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies v t e companies of the nasdaq index st century fox activision blizzard adobe systems akamai technologies alexion pharmaceuticals alphabet amazoncom american airlines group amgen analog devices apple applied materials autodesk automatic data processing baidu biogen biomarin pharmaceutical broadcom limited ca technologies celgene cerner charter communications check point cintas cisco systems citrix systems cognizant comcast costco csx ctripcom international dentsply sirona discovery communications dish network dollar tree ebay electronic arts expedia express scripts facebook fastenal fiserv gilead sciences hasbro henry schein hologic idexx laboratories illumina incyte intel intuit intuitive surgical j b hunt transport services jdcom klatencor kraft heinz lam research liberty global liberty interactive marriott international mattel maxim integrated products mercadolibre microchip technology micron technology microsoft mondelez international monster beverage mylan netease netflix norwegian cruise line nvidia oreilly auto parts paccar paychex paypal qualcomm regeneron ross stores seagate technology shire sirius xm holdings skyworks solutions starbucks symantec tmobile us tesla inc texas instruments the priceline group tractor supply company ulta beauty verisk analytics vertex pharmaceuticals viacom vodafone walgreens boots alliance western digital wynn resorts xilinx retrieved from httpsenwikipediaorgwindexphptitleregeneronoldid categories companies in the nasdaq indexcompanies listed on nasdaqhealth care companies based in new yorkbiotechnology companies of the united statescompanies in the nasdaq biotechnology indexpharmaceutical companies of the united stateslife sciences industryhidden categories pages with login required references or sourcespages using deprecated image syntaxall articles with unsourced statementsarticles with unsourced statements from may  navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages deutschfrançaisукраїнська edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view regeneron  wikipedia regeneron from wikipedia the free encyclopedia jump to navigation search regeneron pharmaceuticals inc type public traded as nasdaq regn nasdaq component sp  component industry pharmaceuticals biotech founded  headquarters tarrytown new york us headquarters area served worldwide key people leonard schleifer ceo george yancopoulos cso revenue  billion net income  billion total assets  billion owner sanofi  website wwwregeneroncom regeneron pharmaceuticals inc is a biotechnology company headquartered in tarrytown new york the company was founded in  originally focused on neurotrophic factors and their regenerative capabilities thus the name it branched out into the study of both cytokine and tyrosine kinase receptors contents  company history  marketed products  technology platforms  financial performance  see also  references  external links company historyedit regeneron has two products in development based on aflibercept a vegf inhibitor and rilonacept an interleukin blocker vegf is a protein that normally stimulates the growth of blood vessels and interleukin is a protein that is normally involved in inflammation on march   bloomberg announced that sanofi and regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to  more than the leading brands it is believed this new drug will greatly reduce heart disease in patients around the world the medicine one in a class of drugs targeting the pcsk gene reduced patients’ average ldl cholesterol levels to as little as  milligrams per deciliter after  weeks in the mid stage study presented on march  at the american college of cardiology meeting in chicagocitation needed in july  the company announced a new global collaboration with sanofi to discover develop and commercialise new immunooncology drugs which could generate more than  billion for regeneron with  million upfront  million for proof of concept data and  million from the development of regn marketed productsedit eylea aflibercept injection approved by the us food and drug administration fda in november  eylea developed to treat a common cause of blindness in the elderly arcalyst rilonacept for specific rare autoinflammatory conditions approved by the fda in february  zaltrap aflibercept injection for metastatic colorectal cancer approved by the fda in august  praluent alirocumab indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease ascvd who require additional lowering of lowdensity lipoprotein ldl cholesterol approved by fda on  july   technology platformsedit trap fusion proteins regeneron’s novel and patented trap technology creates highaffinity product candidates for many types of signaling molecules including growth factors and cytokines the trap technology involves fusing two distinct fully human receptor components and a fully human immunoglobuling constant region fully human monoclonal antibodies regeneron has developed a suite velocisuite of patented technologies including velocimmune and velocimab that allow regeneron scientists to determine the best targets for therapeutic intervention and rapidly generate highquality fully human antibodies drug candidates addressing these targets financial performanceedit financial year revenue ref   billion    billion    billion    billion  see alsoedit biotech and pharmaceutical companies in the new york metropolitan area referencesedit  a b c d e httpfilesshareholdercomdownloadsregnxxccdacederegnnewsgeneralreleasespdf  shareholders managers and business summary  traders retrieved april     a b herper matthew august   how two guys from queens are changing drug discovery forbes united states archived from the original on march   retrieved march     regeneron sanofi launch b immunooncology collaboration  gen news highlights  gen   updated struggling sanofi paying b to partner with regeneron on immunooncology  fiercebiotech   regulators approve a drug for an eye condition the new york times associated press november   registration required  fda approves zaltrap for metastatic colorectal cancer press release us food and drug administration august   archived from the original on june     httpwwwfdagovnewseventsnewsroompressannouncementsucmhtm  susana magadán mompó and áfrica gonzálezfernández human monoclonal antibodies from transgenic mice chapter  in human monoclonal antibodies methods and protocols ed michael steinitz springer sciencebusiness media  isbn   regeneron pharmaceuticals inc  annual report form k xbrl united states securities and exchange commission february     regeneron pharmaceuticals inc  annual report form k xbrl united states securities and exchange commission february    external linksedit official website business data for regeneron google finance yahoo finance reuters sec filings success long in coming for eylea a vision treatment v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies v t e companies of the nasdaq index st century fox activision blizzard adobe systems akamai technologies alexion pharmaceuticals alphabet amazoncom american airlines group amgen analog devices apple applied materials autodesk automatic data processing baidu biogen biomarin pharmaceutical broadcom limited ca technologies celgene cerner charter communications check point cintas cisco systems citrix systems cognizant comcast costco csx ctripcom international dentsply sirona discovery communications dish network dollar tree ebay electronic arts expedia express scripts facebook fastenal fiserv gilead sciences hasbro henry schein hologic idexx laboratories illumina incyte intel intuit intuitive surgical j b hunt transport services jdcom klatencor kraft heinz lam research liberty global liberty interactive marriott international mattel maxim integrated products mercadolibre microchip technology micron technology microsoft mondelez international monster beverage mylan netease netflix norwegian cruise line nvidia oreilly auto parts paccar paychex paypal qualcomm regeneron ross stores seagate technology shire sirius xm holdings skyworks solutions starbucks symantec tmobile us tesla inc texas instruments the priceline group tractor supply company ulta beauty verisk analytics vertex pharmaceuticals viacom vodafone walgreens boots alliance western digital wynn resorts xilinx retrieved from httpsenwikipediaorgwindexphptitleregeneronoldid categories companies in the nasdaq indexcompanies listed on nasdaqhealth care companies based in new yorkbiotechnology companies of the united statescompanies in the nasdaq biotechnology indexpharmaceutical companies of the united stateslife sciences industryhidden categories pages with login required references or sourcespages using deprecated image syntaxall articles with unsourced statementsarticles with unsourced statements from may  navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages deutschfrançaisукраїнська edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft regeneron  wikipedia regeneron from wikipedia the free encyclopedia jump to navigation search regeneron pharmaceuticals inc type public traded as nasdaq regn nasdaq component sp  component industry pharmaceuticals biotech founded  headquarters tarrytown new york us headquarters area served worldwide key people leonard schleifer ceo george yancopoulos cso revenue  billion net income  billion total assets  billion owner sanofi  website wwwregeneroncom regeneron pharmaceuticals inc is a biotechnology company headquartered in tarrytown new york the company was founded in  originally focused on neurotrophic factors and their regenerative capabilities thus the name it branched out into the study of both cytokine and tyrosine kinase receptors contents  company history  marketed products  technology platforms  financial performance  see also  references  external links company historyedit regeneron has two products in development based on aflibercept a vegf inhibitor and rilonacept an interleukin blocker vegf is a protein that normally stimulates the growth of blood vessels and interleukin is a protein that is normally involved in inflammation on march   bloomberg announced that sanofi and regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to  more than the leading brands it is believed this new drug will greatly reduce heart disease in patients around the world the medicine one in a class of drugs targeting the pcsk gene reduced patients’ average ldl cholesterol levels to as little as  milligrams per deciliter after  weeks in the mid stage study presented on march  at the american college of cardiology meeting in chicagocitation needed in july  the company announced a new global collaboration with sanofi to discover develop and commercialise new immunooncology drugs which could generate more than  billion for regeneron with  million upfront  million for proof of concept data and  million from the development of regn marketed productsedit eylea aflibercept injection approved by the us food and drug administration fda in november  eylea developed to treat a common cause of blindness in the elderly arcalyst rilonacept for specific rare autoinflammatory conditions approved by the fda in february  zaltrap aflibercept injection for metastatic colorectal cancer approved by the fda in august  praluent alirocumab indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease ascvd who require additional lowering of lowdensity lipoprotein ldl cholesterol approved by fda on  july   technology platformsedit trap fusion proteins regeneron’s novel and patented trap technology creates highaffinity product candidates for many types of signaling molecules including growth factors and cytokines the trap technology involves fusing two distinct fully human receptor components and a fully human immunoglobuling constant region fully human monoclonal antibodies regeneron has developed a suite velocisuite of patented technologies including velocimmune and velocimab that allow regeneron scientists to determine the best targets for therapeutic intervention and rapidly generate highquality fully human antibodies drug candidates addressing these targets financial performanceedit financial year revenue ref   billion    billion    billion    billion  see alsoedit biotech and pharmaceutical companies in the new york metropolitan area referencesedit  a b c d e httpfilesshareholdercomdownloadsregnxxccdacederegnnewsgeneralreleasespdf  shareholders managers and business summary  traders retrieved april     a b herper matthew august   how two guys from queens are changing drug discovery forbes united states archived from the original on march   retrieved march     regeneron sanofi launch b immunooncology collaboration  gen news highlights  gen   updated struggling sanofi paying b to partner with regeneron on immunooncology  fiercebiotech   regulators approve a drug for an eye condition the new york times associated press november   registration required  fda approves zaltrap for metastatic colorectal cancer press release us food and drug administration august   archived from the original on june     httpwwwfdagovnewseventsnewsroompressannouncementsucmhtm  susana magadán mompó and áfrica gonzálezfernández human monoclonal antibodies from transgenic mice chapter  in human monoclonal antibodies methods and protocols ed michael steinitz springer sciencebusiness media  isbn   regeneron pharmaceuticals inc  annual report form k xbrl united states securities and exchange commission february     regeneron pharmaceuticals inc  annual report form k xbrl united states securities and exchange commission february    external linksedit official website business data for regeneron google finance yahoo finance reuters sec filings success long in coming for eylea a vision treatment v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies v t e companies of the nasdaq index st century fox activision blizzard adobe systems akamai technologies alexion pharmaceuticals alphabet amazoncom american airlines group amgen analog devices apple applied materials autodesk automatic data processing baidu biogen biomarin pharmaceutical broadcom limited ca technologies celgene cerner charter communications check point cintas cisco systems citrix systems cognizant comcast costco csx ctripcom international dentsply sirona discovery communications dish network dollar tree ebay electronic arts expedia express scripts facebook fastenal fiserv gilead sciences hasbro henry schein hologic idexx laboratories illumina incyte intel intuit intuitive surgical j b hunt transport services jdcom klatencor kraft heinz lam research liberty global liberty interactive marriott international mattel maxim integrated products mercadolibre microchip technology micron technology microsoft mondelez international monster beverage mylan netease netflix norwegian cruise line nvidia oreilly auto parts paccar paychex paypal qualcomm regeneron ross stores seagate technology shire sirius xm holdings skyworks solutions starbucks symantec tmobile us tesla inc texas instruments the priceline group tractor supply company ulta beauty verisk analytics vertex pharmaceuticals viacom vodafone walgreens boots alliance western digital wynn resorts xilinx retrieved from httpsenwikipediaorgwindexphptitleregeneronoldid categories companies in the nasdaq indexcompanies listed on nasdaqhealth care companies based in new yorkbiotechnology companies of the united statescompanies in the nasdaq biotechnology indexpharmaceutical companies of the united stateslife sciences industryhidden categories pages with login required references or sourcespages using deprecated image syntaxall articles with unsourced statementsarticles with unsourced statements from may  navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages deutschfrançaisукраїнська edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view regeneron regeneron  twitter skip to content home home home current page moments moments moments current page search query search twitter saved searches remove in this conversation verified accountprotected tweets  suggested users verified accountprotected tweets  verified accountprotected tweets  language english bahasa indonesia bahasa melayu català čeština dansk deutsch english uk español filipino français hrvatski italiano magyar nederlands norsk polski português română slovenčina suomi svenska tiếng việt türkçe ελληνικά български език русский српски українська мова עִבְרִית العربية فارسی मराठी हिन्दी বাংলা ગુજરાતી தமிழ் ಕನ್ನಡ ภาษาไทย 한국어    have an account log in have an account remember me · forgot password new to twitter sign up regeneronverified account regeneron tweets tweets current page  following following  followers followers k likes likes    more likes unmute regeneron mute regeneron follow following unfollow blocked unblock pending cancel regeneronverified account regeneron official twitter channel for regeneron we turn science into medicine for people with serious diseases view our terms of engagement here httpowlydvs  tarrytown ny regeneroncom joined march   photos and videos photos and videos tweets tweets tweets current page tweets  replies media you blocked regeneron are you sure you want to view these tweets viewing tweets wont unblock regeneron yes view profile close regeneron followed pinned tweet regeneron‏verified account regeneron mar  more copy link to tweet embed tweet george regeneronsts alumnus regn pres  cso takes a selfie w the finalistspictwittercomjmxtmeat  reply  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo regeneron‏verified account regeneron h hours ago more copy link to tweet embed tweet regeneronsts alumni interning regn this summer met w george  colleagues to talk science  value of stem what a talent pipelinepictwittercomufdumyhuu  replies  retweet  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo regeneron‏verified account regeneron h hours ago more copy link to tweet embed tweet rt societyscience guess whos at regeneron headquarters regeneronsts sspalumnipictwittercomadjukuge  replies  retweets  likes reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo regeneron‏verified account regeneron jul  more copy link to tweet embed tweet cool stem news from the girlscouts httpbitlytwutr  we love the new science engineering and robotics badgespictwittercomvojstekfr  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo regeneron‏verified account regeneron jul  more copy link to tweet embed tweet watch this interview with dme patient maryanne and the steps she’s taken to protect her vision httpbitlyprwucw  via ktvn  replies  retweets  likes reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo regeneron‏verified account regeneron jul  more copy link to tweet embed tweet rt jgreid doing techtonics podcast with venturevalkyrie and dshaywitz was so fun im going to livetweet my first listen httpst…  reply  retweets  likes reply  retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo regeneron retweeted claudia gonzagaj‏ cgonzagaj jul  more copy link to tweet embed tweet the science talent search regeneron for  opens august st for high school students interested in science httpssocietyforsciencetfaformsnet   replies  retweet  likes reply retweet  retweeted  like liked thanks twitter will use this to make your timeline better undo regeneron‏verified account regeneron jul  more copy link to tweet embed tweet regeneron retweeted shannon sweeney kate phillips hr director discussed our industrial ops  product supply team at albanybizreview power breakfasthttpstwittercomalbbizshannonstatus … regeneron added shannon sweeney albbizshannon the majority of people working at regeneron are millennials  to  percent as an estimate albbizbfast  replies  retweets  likes reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo regeneron‏verified account regeneron jul  more copy link to tweet embed tweet the world definitely needs these great minds winning team of todays public health challenge developed an ebola survivor observation systempictwittercomfcmokdp  replies  retweets  like reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo regeneron‏verified account regeneron jul  more copy link to tweet embed tweet stay on your path  the world needs you hala to young scientists thejunioracademy global stem alliance summit  replies  retweet  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo regeneron‏verified account regeneron jul  more copy link to tweet embed tweet innovation starts with a problem that needs a solution  vp citizenship hala mirza nyasciences global stem alliance summitpictwittercomlwbkyjenh  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo regeneron‏verified account regeneron jul  more copy link to tweet embed tweet we are proud to sponsor nyasciences thejunioracademy of  fostering the next generation of young scientistshttpowlygcwudooj   replies  retweet  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo regeneron‏verified account regeneron jul  more copy link to tweet embed tweet regn  sanofigenzyme receive positive chmp opinion for atopicdermatitis treatment httpowlyizddolbx   replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo regeneron‏verified account regeneron jul  more copy link to tweet embed tweet hs science stars be on the lookout for the  regeneronsts application learn more about the program httpswwwregeneroncomsciencetalentsearch …pictwittercomjxxdtcvvs  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo regeneron‏verified account regeneron jul  more copy link to tweet embed tweet congrats to columbiamed’s ori lieberman and dr ewoud schmidt winners of the  regeneron prizepictwittercomwzqwraxp  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo regeneron‏verified account regeneron jul  more copy link to tweet embed tweet calling all rising hs seniors their parents teachers  mentors – sign up to get updates on the  regeneronsts httpowlyteldbcx   replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo regeneron‏verified account regeneron jul  more copy link to tweet embed tweet  marks the th year of the regeneron prize learn more about our commitment to advancing stem at all levels httpowlywpidnoxz   replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo regeneron‏verified account regeneron jul  more copy link to tweet embed tweet the application for the  regeneronsts opens on  register for info  updates httpowlyteldbcx   replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo regeneron‏verified account regeneron jul  more copy link to tweet embed tweet participants of the boces questariii teacher intern program took a tour of our rensselaer site and learned about careers in biotech  replies  retweets  likes reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo regeneron‏verified account regeneron jul  more copy link to tweet embed tweet we’re excited to announce this year’s recipients of the regeneron prize for creative innovation httpowlyqybldbfqr   replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo regeneron‏verified account regeneron jul  more copy link to tweet embed tweet  the number of uk volunteers whose genetic data we’re sequencing with ukbiobank gsk techreview tdhttpswwwtechnologyreviewcomlistscompaniesintroregeneron …  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo regeneron hasnt tweeted yet back to top ↑ loading seems to be taking a while twitter may be over capacity or experiencing a momentary hiccup try again or visit twitter status for more information new to twitter sign up now to get your own personalized timeline sign up you may also like · refresh false   twitter about help center terms privacy policy cookies ads info close choose a trend location dismiss close previous next close go to a persons profile saved searches remove in this conversation verified accountprotected tweets  suggested users verified accountprotected tweets  verified accountprotected tweets  close promote this tweet close block cancel block add a location to your tweets when you tweet with a location twitter stores that location you can switch location onoff before each tweet and always have the option to delete your location history learn more turn location on not now close share location results from send close your lists close create a new list list name description under  characters optional privacy public · anyone can follow this list private · only you can access this list save list close close copy link to tweet heres the url for this tweet copy it to easily share with friends close embed this tweet embed this video add this tweet to your website by copying the code below learn more add this video to your website by copying the code below learn more hmm there was a problem reaching the server try again include parent tweet include media by embedding twitter content in your website or app you are agreeing to the twitter developer agreement and developer policy preview close why youre seeing this ad close log in to twitter remember me · forgot password dont have an account sign up » close sign up for twitter not on twitter sign up tune into the things you care about and get updates as they happen sign up have an account log in » close twoway sending and receiving short codes country code for customers of united states  any canada  any united kingdom  vodafone orange  o brazil  nextel tim haiti  digicel voila ireland  vodafone o india  bharti airtel videocon reliance indonesia  axis  telkomsel indosat xl axiata italy  wind  vodafone » see sms short codes for other countries close confirmation close   close skip all welcome home this timeline is where you’ll spend most of your time getting instant updates about what matters to you tweets not working for you hover over the profile pic and click the following button to unfollow any account say a lot with a little when you see a tweet you love tap the heart — it lets the person who wrote it know you shared the love spread the word the fastest way to share someone else’s tweet with your followers is with a retweet tap the icon to send it instantly join the conversation add your thoughts about any tweet with a reply find a topic you’re passionate about and jump right in learn the latest get instant insight into what people are talking about now get more of what you love follow more accounts to get instant updates about topics you care about find whats happening see the latest conversations about any topic instantly never miss a moment catch up instantly on the best stories happening as they unfold back next next tweet from user flashratings  principles facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings principles  flashratings mission is to provide you  the investor  with as much honest and professional research on your investments as possible  we believe its much better to get a multitude of credible opinions on an investment than to arbitrarily follow any single advisor  be it your banker a friend or a tv pundit  flashratings does not provide advice our job is to accurately and objectively report on analysts credible research and opinions the only advice flashratings will ever give you is to absorb as much fundamental research and different opinions as possible and make your own decisions  flashratings favors covering analysts with proven track records but will cover all analysts as long as their research is honest and professional sign up » creative commons — attributionsharealike  unported — cc bysa  skip to content menu help us build a vibrant collaborative global commons donate now creative commons creative commons license deed attributionsharealike  unported cc bysa  this is a humanreadable summary of and not a substitute for the license disclaimer you are free to share — copy and redistribute the material in any medium or format adapt — remix transform and build upon the material for any purpose even commercially the licensor cannot revoke these freedoms as long as you follow the license terms under the following terms attribution — you must give appropriate credit provide a link to the license and indicate if changes were made you may do so in any reasonable manner but not in any way that suggests the licensor endorses you or your use attribute this work sharealike — if you remix transform or build upon the material you must distribute your contributions under the same license as the original no additional restrictions — you may not apply legal terms or technological measures that legally restrict others from doing anything the license permits notices you do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation no warranties are given the license may not give you all of the permissions necessary for your intended use for example other rights such as publicity privacy or moral rights may limit how you use the material learn more about cc licensing or use the license for your own material this content is freely available under simple legal terms because of creative commons a nonprofit that survives on donations if you love this content and love that its free for everyone please consider a donation to support our work make a donation this page is available in the following languages castellano castellano españa català dansk deutsch english esperanto français galego hrvatski indonesia italiano latviski lietuvių melayu nederlands norsk polski português português br română slovenščina suomeksi svenska türkçe íslenska česky ελληνικά беларуская русский українська العربية پارسی     한국어 this content is freely available under simple legal terms because of creative commons a nonprofit that survives on donations if you love this content and love that its free for everyone please consider a donation to support our work when you share everyone wins contribute today to creative commons     disclaimer this deed highlights only some of the key features and terms of the actual license it is not a license and has no legal value you should carefully review all of the terms and conditions of the actual license before using the licensed material creative commons is not a law firm and does not provide legal services distributing displaying or linking to this deed or the license that it summarizes does not create a lawyerclient or any other relationship what does attribute this work mean the page you came from contained embedded licensing metadata including how the creator wishes to be attributed for reuse you can use the html here to cite the work doing so will also include metadata on your page so that others can find the original work as well the applicable mediation rules will be designated in the copyright notice published with the work or if none then in the request for mediation unless otherwise designated in a copyright notice attached to the work the uncitral arbitration rules apply to any arbitration more info if supplied you must provide the name of the creator and attribution parties a copyright notice a license notice a disclaimer notice and a link to the material cc licenses prior to version  also require you to provide the title of the material if supplied and may have other slight differences more info in  you must indicate if you modified the material and retain an indication of previous modifications in  and earlier license versions the indication of changes is only required if you create a derivative marking guide more info you may also use a license listed as compatible at httpscreativecommonsorgcompatiblelicenses more info a commercial use is one primarily intended for commercial advantage or monetary compensation more info merely changing the format never creates a derivative more info the license prohibits application of effective technological measures defined with reference to article  of the wipo copyright treaty more info the rights of users under exceptions and limitations such as fair use and fair dealing are not affected by the cc licenses more info you may need to get additional permissions before using the material as you intend more info flashratings  contact us facebook autocomplete demo post a rating  month price target   trending sign up log in contact flashratings your emotional state excited confused worried upset panicked angry regeneron pharmaceuticals inc  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports regeneron pharmaceuticals inc  product pipeline review regeneron pharmaceuticals inc  product pipeline review   wgr  april  global  pages global markets direct description table of content sample report enquiry before buy related reports regeneron pharmaceuticals inc  product pipeline review   summary global markets direct’s ‘regeneron pharmaceuticals inc  product pipeline review  ’ provides an overview of the regeneron pharmaceuticals inc’s pharmaceutical research and development focus the report provides comprehensive information on the therapeutics under development by regeneron pharmaceuticals inc complete with analysis by stage of development drug target mechanism of action moa route of administration roa and molecule type the report also covers the descriptive pharmacological action of the therapeutics its complete research and development history and the dormant and discontinued projects global markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites clinical trial registries conferences sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis the report helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage note certain sections in the report may be removed or altered based on the availability and relevance of data scope  the report provides a snapshot of the pipeline therapeutic landscape of regeneron pharmaceuticals inc  the report provides overview of regeneron pharmaceuticals inc including its business description key facts and locations and subsidiaries  the report features descriptive drug profiles for the pipeline products which includes product description descriptive moa rd brief licensing and collaboration details  other developmental activities  the report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages  the report assesses regeneron pharmaceuticals inc’s pipeline therapeutics based on drug target mechanism of action moa route of administration roa and molecule type  the report features regeneron pharmaceuticals inc’s outlicensed and partnered product portfolio and summarizes its dormant and discontinued projects reasons to buy  evaluate regeneron pharmaceuticals inc’s strategic position with total access to detailed information on its product pipeline  gain strategically significant competitor information analysis and insights to formulate effective rd strategies  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  identify and understand important and diverse types of therapeutics under development for regeneron pharmaceuticals inc  identify potential new clients or partners in the target demographic  plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics  devise corrective measures for pipeline projects by understanding regeneron pharmaceuticals inc’s pipeline depth and focus of pipeline therapeutics  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope table of contents table of contents  list of tables  list of figures  introduction  global markets direct report coverage  regeneron pharmaceuticals inc snapshot  regeneron pharmaceuticals inc overview  key information  key facts  regeneron pharmaceuticals inc  research and development overview  key therapeutic areas  regeneron pharmaceuticals inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  pipeline products  combination treatment modalities  pipeline products  partnered products  partnered productscombination treatment modalities  regeneron pharmaceuticals inc  pipeline products glance  regeneron pharmaceuticals inc  late stage pipeline products  preregistration productscombination treatment modalities  phase iii productscombination treatment modalities  regeneron pharmaceuticals inc  clinical stage pipeline products  phase ii productscombination treatment modalities  phase i productscombination treatment modalities  regeneron pharmaceuticals inc  early stage pipeline products  preclinical productscombination treatment modalities  discovery productscombination treatment modalities  regeneron pharmaceuticals inc  drug profiles  aflibercept  product description  mechanism of action  rd progress  alirocumab  product description  mechanism of action  rd progress  sarilumab  product description  mechanism of action  rd progress  dupilumab  product description  mechanism of action  rd progress  suptavumab  product description  mechanism of action  rd progress  fasinumab  product description  mechanism of action  rd progress  aflibercept  nesvacumab  product description  mechanism of action  rd progress  aflibercept  rinucumab  product description  mechanism of action  rd progress  evinacumab  product description  mechanism of action  rd progress  trevogrumab  product description  mechanism of action  rd progress  zivaflibercept recombinant  product description  mechanism of action  rd progress  regn  product description  mechanism of action  rd progress  regn  product description  mechanism of action  rd progress  regn  product description  mechanism of action  rd progress  monoclonal antibodies for ebola virus infection  product description  mechanism of action  rd progress  monoclonal antibodies for middle east respiratory syndrome  product description  mechanism of action  rd progress  monoclonal antibody to agonize gitr for oncology  product description  mechanism of action  rd progress  monoclonal antibody to inhibit lag for oncology  product description  mechanism of action  rd progress  monoclonal antibody to inhibit pdl for oncology  product description  mechanism of action  rd progress  oligonucleotides to inhibit transthyretin for amyloidosis  product description  mechanism of action  rd progress  regn  product description  mechanism of action  rd progress  monoclonal antibodies for blood cancer and solid tumor  product description  mechanism of action  rd progress  regeneron pharmaceuticals inc  pipeline analysis  regeneron pharmaceuticals inc  pipeline products by target  regeneron pharmaceuticals inc  pipeline products by route of administration  regeneron pharmaceuticals inc  pipeline products by molecule type  regeneron pharmaceuticals inc  pipeline products by mechanism of action  regeneron pharmaceuticals inc  recent pipeline updates  regeneron pharmaceuticals inc  dormant projects  regeneron pharmaceuticals inc  discontinued pipeline products  discontinued pipeline product profiles  crotedumab  dapiclermin  enoticumab  nesvacumab  regn  regn  rilonacept  zivaflibercept recombinant  regeneron pharmaceuticals inc  company statement  regeneron pharmaceuticals inc  locations and subsidiaries  head office  other locations  subsidiaries  regeneron pharmaceuticals inc  key manufacturing facilities  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of tables regeneron pharmaceuticals inc key information  regeneron pharmaceuticals inc key facts  regeneron pharmaceuticals inc  pipeline by indication   regeneron pharmaceuticals inc  pipeline by stage of development   regeneron pharmaceuticals inc  monotherapy products in pipeline   regeneron pharmaceuticals inc  combination treatment modalities in pipeline   regeneron pharmaceuticals inc  partnered products in pipeline   regeneron pharmaceuticals inc  partnered products combination treatment modalities   regeneron pharmaceuticals inc  preregistration   regeneron pharmaceuticals inc  phase iii   regeneron pharmaceuticals inc  phase ii   regeneron pharmaceuticals inc  phase i   regeneron pharmaceuticals inc  preclinical   regeneron pharmaceuticals inc  discovery   regeneron pharmaceuticals inc  pipeline by target   regeneron pharmaceuticals inc  pipeline by route of administration   regeneron pharmaceuticals inc  pipeline by molecule type   regeneron pharmaceuticals inc  pipeline products by mechanism of action   regeneron pharmaceuticals inc  recent pipeline updates   regeneron pharmaceuticals inc  dormant developmental projects  regeneron pharmaceuticals inc  discontinued pipeline products   regeneron pharmaceuticals inc other locations  regeneron pharmaceuticals inc subsidiaries  regeneron pharmaceuticals inc key manufacturing facilities  list of figures regeneron pharmaceuticals inc  pipeline by top  indication   regeneron pharmaceuticals inc  pipeline by stage of development   regeneron pharmaceuticals inc  monotherapy products in pipeline   regeneron pharmaceuticals inc  partnered products in pipeline   regeneron pharmaceuticals inc  pipeline by top  target   regeneron pharmaceuticals inc  pipeline by top  route of administration   regeneron pharmaceuticals inc  pipeline by top  molecule type   regeneron pharmaceuticals inc  pipeline products by top  mechanism of action   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send facebook autocomplete demo post a rating  month price target   home trending sign up log in analyst ranking   name measured ratings sucess rate avg return  mizuho      credit suisse      jefferies      cantor fitzgerald      bank of america merrill lynch      jmp securities      goldman sachs      raymond james      fbr capital markets      william blair     medicines  committed to solving the body’s most complex mysteries regeneron nasdaq regn is a leading science and technology company delivering lifetransforming medicines for serious diseases read on our robust research and development engine allows us to discover therapies that could have a profound impact on patient health read on our goal is to address serious medical conditions across multiple and diverse therapeutic areas our fdaapproved medicines are only the beginning of our longterm commitment to solve the human bodys most complex mysteries read on in addition to our work to invent new and needed medicines we are focused on improving our world and operating with the highest standards of integrity we are proud not only of what we do but how we do it read on push the limits of science our goal is to address serious medical conditions across multiple and diverse therapeutic areas our fdaapproved medicines are only the beginning of our longterm commitment to solve the human bodys most complex mysteries full prescribing information including boxed warning you are now leaving regeneroncom the site you are about to visit is maintained by a third party who is solely responsible for its content we encourage you to read the privacy policy of every website you visit cancel continue you are now leaving regeneroncom to visit another regeneron pharmaceuticals website cancel continue confirmed thank you for reaching out to us well be in touch soon careers at regeneron  regeneron jobs regeneron search jobs recent searches skip to main content toggle navigation welcome to careers at regeneron job openings interested in working with regeneron take the first step today by joining our talent network talent network watch video recentaccolades recently viewed jobs news roomread our press releases and recent newsnewsroomregeneroncomfollow us on twitter to stay connected with the latest info on careers at regenerontweets by regeneron contact us  regeneron information regeneron nasdaq regn is a leading science and technology company delivering lifetransforming medicines for serious diseases read on our robust research and development engine allows us to discover therapies that could have a profound impact on patient health read on our goal is to address serious medical conditions across multiple and diverse therapeutic areas our fdaapproved medicines are only the beginning of our longterm commitment to solve the human bodys most complex mysteries read on in addition to our work to invent new and needed medicines we are focused on improving our world and operating with the highest standards of integrity we are proud not only of what we do but how we do it read on contact us for information about corporate communications media relations investor relations or business development read our privacy policy to understand how we protect your privacy and how we may collect use and share information privacy policy please complete the form below required fields business development corporate communications investor relations media relations preferred contact method email telephone alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming other nonus united states ireland afghanistan albania algeria andorra angola antigua and barbuda argentina armenia australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bhutan bolivia bosnia and herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodia cameroon canada cape verde central african republic chad chile china colombi comoros congo brazzaville congo costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic east timor timor timur ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia fiji finland france gabon gambia the georgia germany ghana greece grenada guatemala guinea guineabissau guyana haiti honduras hungary iceland india indonesia iran iraq israel italy jamaica japan jordan kazakhstan kenya kiribati korea north korea south kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macedonia madagascar malawi malaysia maldives mali malta marshall islands mauritania mauritius mexico micronesia moldova monaco mongolia morocco mozambique myanmar namibia nauru nepa netherlands new zealand nicaragua niger nigeria norway oman pakistan palau panama papua new guinea paraguay peru philippines poland portugal qatar romania russia rwanda saint kitts and nevis saint lucia saint vincent samoa san marino sao tome and principe saudi arabia senegal serbia and montenegro seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tonga trinidad and tobago tunisia turkey turkmenistan tuvalu uganda ukraine united arab emirates united kingdom uruguay uzbekistan vanuatu vatican city venezuela vietnam yemen zambia zimbabwe robot verification failed please try again for information about job opportunities please visit our careers portal for information about products healthcare professionals patients or caregivers requesting specific product information reporting an adverse event or reporting a product complaint for a regeneron product are requested to contact our medical information department at regenu  for further information please submit medical information inquiries here our locations usa corporate headquarters  old saw mill river road tarrytown ny    corporate headquarters  old saw mill river road tarrytown ny    basking ridge clinical operations  biostats  allen road basking ridge nj    basking ridge clinical operations  biostats  allen road basking ridge nj    industrial operations and product supply  columbia turnpike rensselaer ny    industrial operations and product supply  columbia turnpike rensselaer ny    europe european business office europa house harcourt centre harcourt street dublin   wr ireland     european business office europa house harcourt centre harcourt street dublin   wr ireland     ireland industrial operations and product supply raheen business park limerick ireland    ireland industrial operations and product supply raheen business park limerick ireland    london office  st james’s square london swy lb london office  st james’s square london swy lb you are now leaving regeneroncom the site you are about to visit is maintained by a third party who is solely responsible for its content we encourage you to read the privacy policy of every website you visit cancel continue you are now leaving regeneroncom to visit another regeneron pharmaceuticals website cancel continue confirmed thank you for reaching out to us well be in touch soon pipeline  a powerful research and development engine regeneron nasdaq regn is a leading science and technology company delivering lifetransforming medicines for serious diseases read on our robust research and development engine allows us to discover therapies that could have a profound impact on patient health read on our goal is to address serious medical conditions across multiple and diverse therapeutic areas our fdaapproved medicines are only the beginning of our longterm commitment to solve the human bodys most complex mysteries read on in addition to our work to invent new and needed medicines we are focused on improving our world and operating with the highest standards of integrity we are proud not only of what we do but how we do it read on a powerful research and development engine our robust pipeline of investigational product candidates strives to address many serious medical conditions including asthma pain cancer and infectious diseases phase  trials regn feld antibody regn feld antibodyallergic disease regn regn pd antibodycancer regn cdcd antibody regn cdxcd antibodycancer also in combination with regn regn antibody to ebola virus regn antibody to ebola virusebola virus infection regn regn activin a antibodyfibrodysplasia ossificans progressiva fop trevogrumab gdf antibody trevogrumab gdf antibodycombination with regn regn regn il antibodyinflammatory diseases regn regn lag antibodycancer phase  trials trevogrumab trevogrumab gdf antibodyskeletal muscle disorders dupilumab ilr antibody dupilumab ilr antibodyatopic dermatitis in children eosinophilic esophagitis sarilumab ilr antibody sarilumab ilr antibodyjuvenile idiopathic arthritis evinacumab angptl antibody evinacumab angptl antibodyhomozygous familial hypercholesterolemia severe forms of hyperlipidemia regn nesvacumab ang antibody  aflibercept nesvacumab  aflibercept ang antibody  afliberceptwet agerelated macular degeneration diabetic macular edema regn pd antibody regn pd antibodyadvanced cutaneous squamous cell carcinoma phase  trials alirocumab pcsk antibody alirocumab pcsk antibodyldl cholesterol cardiovascular events dupilumab ilr antibody dupilumab ilr antibodyasthma and nasal polyps aflibercept vegftrap aflibercept vegftrapdiabetic retinopathy without diabetic macular edema fasinumab† ngf antibody fasinumab† ngf antibodypain due to osteoarthritis regn rsv antibody regn rsv antibodyrespiratory syncytial virus infection trials footnotes  in collaboration with sanofi  in collaboration with sanofi  in collaboration with bayer healthcare  in collaboration with bayer healthcare † in collaboration with teva and mitsubishi tanabe † in collaboration with teva and mitsubishi tanabe this graphic displays pipeline drug candidates currently undergoing clinical testing in a variety of diseases the safety and efficacy of these drug candidates have not been fully evaluated by any regulatory authorities for the indications described in this section you are now leaving regeneroncom the site you are about to visit is maintained by a third party who is solely responsible for its content we encourage you to read the privacy policy of every website you visit cancel continue you are now leaving regeneroncom to visit another regeneron pharmaceuticals website cancel continue confirmed thank you for reaching out to us well be in touch soon regn  summary for regeneron pharmaceuticals inc  yahoo financehomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoreyahoosearchsearchus markets open in  hr  minssp futures dow futures regeneron pharmaceuticals inc regnnasdaqgs  nasdaqgs delayed price currency in usdadd to watchlist at close pm edtpeople also watchalxnbiibcelgvrtxbmrnsummaryconversationsstatisticsprofilefinancialsoptionsholdershistorical dataanalystsddmmytdyymaxfull screenprevious closeopenbid x ask x days range   week range  volumeavg volumemarket capbbetape ratio ttmeps ttmearnings dateaug  dividend  yieldna naexdividend datenay target esttrade prices are not sourced from all marketsallnewspress releasesmarketwatch•yesterdayignore the obamacare fight in congress and buy these  healthcare stocksregardless of how the debate over repealing the affordable care act plays out there are plenty of reason to like health care as a longterm investment says jeff reevesreactions click to view reactionssponsoredbanyan hillits easily the no  stock to ownpaul reveals his no  investment for   an investment that he says will hand you a rare onceinalifetime opportunity to become zacks• days agocan regeneron pharma regn pull a surprise in q earningsregeneron pharmaceuticals inc regn is scheduled to release secondquarter  results on aug  and we expect focus on eyleas performanceyahoo small businessdata disclaimerhelpsuggestionsprivacyabout our adsterms updated regeneron pharmaceuticals  delivering lifetransforming medicines regeneron nasdaq regn is a leading science and technology company delivering lifetransforming medicines for serious diseases read on our robust research and development engine allows us to discover therapies that could have a profound impact on patient health read on our goal is to address serious medical conditions across multiple and diverse therapeutic areas our fdaapproved medicines are only the beginning of our longterm commitment to solve the human bodys most complex mysteries read on in addition to our work to invent new and needed medicines we are focused on improving our world and operating with the highest standards of integrity we are proud not only of what we do but how we do it read on make great medicine and then do it again and again science as limitless as our curiosity humbled by possibility make great medicine and then do it again and again science as limitless as our curiosity humbled by possibility regeneron joins the civic  list of most communityminded companies in the united states learn more regeneron newsroom be an engine of invention we embrace progress in science in manufacturing and in what people can expect for their health join our team and help turn science into lifechanging medicine make an impact our momentum is selfpropelled our robust pipeline includes a dozen antibodies in the clinic across multiple therapeutic areas explore regeneron newsroom never stop asking why the drug development process is notoriously rife with bottlenecks never ones to accept the status quo we set out to transform the speed scale and sophistication of drug development through proprietary technologies solutions at work the journey of an idea the regeneron genetics center rgc launched in  with a goal to advance basic science around the world providing clinically valuable information to physicians and patients and helping to identify novel targets for regeneron drug development the journey of the rgc showcases the open collaborative culture at regeneron a place where big ideas are encouraged and a commitment to following the science is paramount read on the people behind the science meet aynur hermann one of the people behind our cuttingedge science with a lifelong passion for science that began in childhood and flourished during years spent in turkey and germany aynur nurtured her ability to push boundaries take leaps and work hard an energetic person with a strong sense of collaboration here aynur talks about her scientific journey and what drives her to turn science into medicine read on you are now leaving regeneroncom the site you are about to visit is maintained by a third party who is solely responsible for its content we encourage you to read the privacy policy of every website you visit cancel continue you are now leaving regeneroncom to visit another regeneron pharmaceuticals website cancel continue confirmed thank you for reaching out to us well be in touch soon regeneron pharmaceuticals  delivering lifetransforming medicines regeneron nasdaq regn is a leading science and technology company delivering lifetransforming medicines for serious diseases read on our robust research and development engine allows us to discover therapies that could have a profound impact on patient health read on our goal is to address serious medical conditions across multiple and diverse therapeutic areas our fdaapproved medicines are only the beginning of our longterm commitment to solve the human bodys most complex mysteries read on in addition to our work to invent new and needed medicines we are focused on improving our world and operating with the highest standards of integrity we are proud not only of what we do but how we do it read on make great medicine and then do it again and again science as limitless as our curiosity humbled by possibility make great medicine and then do it again and again science as limitless as our curiosity humbled by possibility regeneron joins the civic  list of most communityminded companies in the united states learn more regeneron newsroom be an engine of invention we embrace progress in science in manufacturing and in what people can expect for their health join our team and help turn science into lifechanging medicine make an impact our momentum is selfpropelled our robust pipeline includes a dozen antibodies in the clinic across multiple therapeutic areas explore regeneron newsroom never stop asking why the drug development process is notoriously rife with bottlenecks never ones to accept the status quo we set out to transform the speed scale and sophistication of drug development through proprietary technologies solutions at work the journey of an idea the regeneron genetics center rgc launched in  with a goal to advance basic science around the world providing clinically valuable information to physicians and patients and helping to identify novel targets for regeneron drug development the journey of the rgc showcases the open collaborative culture at regeneron a place where big ideas are encouraged and a commitment to following the science is paramount read on the people behind the science meet aynur hermann one of the people behind our cuttingedge science with a lifelong passion for science that began in childhood and flourished during years spent in turkey and germany aynur nurtured her ability to push boundaries take leaps and work hard an energetic person with a strong sense of collaboration here aynur talks about her scientific journey and what drives her to turn science into medicine read on you are now leaving regeneroncom the site you are about to visit is maintained by a third party who is solely responsible for its content we encourage you to read the privacy policy of every website you visit cancel continue you are now leaving regeneroncom to visit another regeneron pharmaceuticals website cancel continue confirmed thank you for reaching out to us well be in touch soon regeneron pharmaceuticals  delivering lifetransforming medicines regeneron nasdaq regn is a leading science and technology company delivering lifetransforming medicines for serious diseases read on our robust research and development engine allows us to discover therapies that could have a profound impact on patient health read on our goal is to address serious medical conditions across multiple and diverse therapeutic areas our fdaapproved medicines are only the beginning of our longterm commitment to solve the human bodys most complex mysteries read on in addition to our work to invent new and needed medicines we are focused on improving our world and operating with the highest standards of integrity we are proud not only of what we do but how we do it read on make great medicine and then do it again and again science as limitless as our curiosity humbled by possibility make great medicine and then do it again and again science as limitless as our curiosity humbled by possibility regeneron joins the civic  list of most communityminded companies in the united states learn more regeneron newsroom be an engine of invention we embrace progress in science in manufacturing and in what people can expect for their health join our team and help turn science into lifechanging medicine make an impact our momentum is selfpropelled our robust pipeline includes a dozen antibodies in the clinic across multiple therapeutic areas explore regeneron newsroom never stop asking why the drug development process is notoriously rife with bottlenecks never ones to accept the status quo we set out to transform the speed scale and sophistication of drug development through proprietary technologies solutions at work the journey of an idea the regeneron genetics center rgc launched in  with a goal to advance basic science around the world providing clinically valuable information to physicians and patients and helping to identify novel targets for regeneron drug development the journey of the rgc showcases the open collaborative culture at regeneron a place where big ideas are encouraged and a commitment to following the science is paramount read on the people behind the science meet aynur hermann one of the people behind our cuttingedge science with a lifelong passion for science that began in childhood and flourished during years spent in turkey and germany aynur nurtured her ability to push boundaries take leaps and work hard an energetic person with a strong sense of collaboration here aynur talks about her scientific journey and what drives her to turn science into medicine read on you are now leaving regeneroncom the site you are about to visit is maintained by a third party who is solely responsible for its content we encourage you to read the privacy policy of every website you visit cancel continue you are now leaving regeneroncom to visit another regeneron pharmaceuticals website cancel continue confirmed thank you for reaching out to us well be in touch soon stock information  latest information on regeneron pharmaceuticals regeneron nasdaq regn is a leading science and technology company delivering lifetransforming medicines for serious diseases read on our robust research and development engine allows us to discover therapies that could have a profound impact on patient health read on our goal is to address serious medical conditions across multiple and diverse therapeutic areas our fdaapproved medicines are only the beginning of our longterm commitment to solve the human bodys most complex mysteries read on in addition to our work to invent new and needed medicines we are focused on improving our world and operating with the highest standards of integrity we are proud not only of what we do but how we do it read on stock information investors  media investors  media stock information nasdaq regn  price   change  na todays high  todays open  week high na volume na todays low  previous close  week low compare benchmark nasdaq nyse sp  amex benchmark area graph ohlc line graph candlestick time intraday  day  month  month  months  year  years  years  years range update from to   the stock information provided is for informational purposes only and is not intended for trading purposes the stock information is provided by esignal stock charts are provided by edgar online both third party services and regeneron pharmaceuticals inc does not maintain or provide information directly to this service stock information is delayed approximately  minutes sign up for email alerts the stock information provided is for informational purposes only and is not intended for trading purposes the stock information is provided by esignal stock charts are provided by nasdaq omx both third party services and regeneron pharmaceuticals inc does not maintain or provide information directly to this service stock information is delayed approximately  minutes   pm et  minimum  minutes delay historic stock lookup adjusted historic prices for the week of july   date open high low close volume jul        jul        jul        jul        january february march april may june july august september october november december   lookup year end stock prices the historical stock information provided is for informational purposes only and is not intended for trading purposes the historical stock information is provided by mergent a third party service and regeneron pharmaceuticals inc does not maintain or provide information directly to this service prices display splitadjusted cost basis per share on that date investment calculator i invested shares dollars usd on january february march april may june july august september october november december   calculate    calculate current value and shares since april   investment date original shares original value current shares current value percent return apr        adjustments there are no adjustments for your investment the investment calculator page and related information is provided by mergent a third party service regeneron pharmaceuticals inc does not maintain this page and is not responsible for the accuracy completeness or timeliness of the information the results are for illustrative purposes only and should not be relied on for investment purposes the timing and price of dividend reinvestments taxes commissions and other factors may affect the values shown please note that historical investment performance is not intended to indicate future performance ownership profile shareholder breakdown shareholder holders values   os shares institution     mutual fund     institutional shareholder rotation shareholder holders values change   os shares change buyers     sellers     net     institutional shareholder concentration shareholder values   os shares top  inst    top  inst    top  inst    total inst    institutional shareholder style shareholder holders values   os shares index     aggresgr     coregrowth     growth     incomevalue     yield     brokerdealer     garp     hedgefund     sectorspecific     specialty     corevalue     deepvalue     top holders institutional investor holder shares held  os shares change filing date sanofi sa     capital world investors     fidelity management  research company     wellington management company llp     the vanguard group inc     blackrock institutional trust company na     state street global advisors us     sands capital management llc     artisan partners limited partnership     loomis sayles  company lp     capital research global investors     polen capital management llc     janus capital management llc     yancopoulos george d     t rowe price associates inc     vagelos p roy     invesco powershares capital management llc     american century investment management inc     norges bank investment management nbim     jennison associates llc     geode capital management llc     managed account advisors llc     clearbridge investments llc     northern trust investments inc     dsm capital partners llc     franklin advisers inc     winslow capital management llc     harding loevner lp     bnp paribas securities corp north america     sustainable growth advisers lp     blackrock financial management inc     bank of america merrill lynch us     orbimed advisors llc     legal  general investment management ltd     mellon capital management corporation     nuveen llc     blackrock investment management uk ltd     pictet asset management ltd     mfs investment management     manning  napier advisors llc     neuberger berman llc     blackrock investment management llc     pinnacle associates ltd     columbia threadneedle investments us     schweizerische nationalbank     bellevue asset management ag     bny mellon asset management     goldman sachs  company inc     southpoint capital advisors lp     sei investments management corporation     ownership data is provided by thomson reuters a third party service and regeneron pharmaceuticals inc does not maintain or provide information directly to this service investor relations  investregeneroncom media relations mediaregeneroncom investor email alerts download center  form k  proxy statement  annual report  environmental sustainability report corporate fact sheet senior management biographies regeneron genetics center fact sheet investor relations  investregeneroncom media relations mediaregeneroncom investor email alerts briefcase briefcase email alerts email alerts downloads downloads rss rss print print share share search search facebook google linkedin twitter email rss